The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output

PLoS Pathogens

Volumn 5, Issue 7, 2009, Pages

  Hadinoto, Vey ^a   Shapiro, Michael ^a   Sun, Chia Chi ^a   Thorley Lawson, David A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; CELL COUNT; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; SALIVA; VIRUS CARRIER; VIRUS INFECTION; VIRUS SHEDDING; WALDEYER RING; BIOLOGICAL MODEL; CELL LINE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HETEROZYGOTE; METABOLISM; MONTE CARLO METHOD; PHYSIOLOGY; POLYMERASE CHAIN REACTION; STATISTICAL MODEL; VIRION; VIROLOGY; VIRUS REPLICATION;

HIRUNDINIDAE; HUMAN HERPESVIRUS 4;

DEOXYRIBONUCLEASE;

B-LYMPHOCYTES; CARRIER STATE; CELL LINE; DEOXYRIBONUCLEASES; EPITHELIAL CELLS; HERPESVIRUS 4, HUMAN; HUMANS; LINEAR MODELS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; POLYMERASE CHAIN REACTION; SALIVA; VIRION; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 70049086022     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000496     Document Type: Article

References (43)

1. Kieff E, Rickinson AB (2007) Epstein-Barr Virus and Its Replication. In: Knipe DM, Howley PM, eds. Fields Virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins. pp 2603-2654.
2. Thorley-Lawson D (2005) EBV persistence and latent infection in vivo. In: ES R, ed. Epstein-Barr Virus. 1st ed. Norfolk, England: Caister Academic Press. pp 309-349.
3. Thorley-Lawson DA (2001) Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 1: 75-82.
4. Hadinoto V, Shapiro M, Greenough TC, Sullivan JL, Luzuriaga K, et al. (2008) On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 111: 1420-1427. (Pubitemid 351213429)
5. Rickinson AB, Kieff E (2007) Epstein-Barr Virus. In: Knipe DM, Howley PM, eds. Fields Virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins. pp 2655-2700.
6. Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350: 1328-1337. (Pubitemid 38375368)
7. Parker GA, Crook T, Bain M, Sara EA, Farrell PJ, et al. (1996) Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13: 2541-2549. (Pubitemid 27046110)
8. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43: 831-840.
9. Niederman JC (1982) Infectious mononucleosis: observations on transmission. Yale J Biol Med 55: 259-264.
10. Niederman JC, Miller G, Pearson HA, Pagano JS, Dowaliby JM (1976) Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx. N Engl J Med 294: 1355-1359.
11. Yao QY, Rickinson AB, Epstein MA (1985) A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer 35: 35-42.
12. Fafi-Kremer S, Morand P, Brion JP, Pavese P, Baccard M, et al. (2005) Longterm shedding of infectious epstein-barr virus after infectious mononucleosis. J Infect Dis 191: 985-989. (Pubitemid 40349816)
13. Haque T, Crawford DH (1997) PCR amplification is more sensitive than tissue culture methods for Epstein-Barr virus detection in clinical material. J Gen Virol 78(Pt 12): 3357-3360. (Pubitemid 27511328)
14. Hislop AD, Kuo M, Drake-Lee AB, Akbar AN, Bergler W, et al. (2005) Tonsillar homing of Epstein-Barr virus-specific CD8+T cells and the virus-host balance. J Clin Invest 115: 2546-2555. (Pubitemid 41266217)
15. Ling PD, Lednicky JA, Keitel WA, Poston DG, White ZS, et al. (2003) The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis 187: 1571-1580.
16. Babcock GJ, Miyashita-Lin EM, Thorley-Lawson DA (2001) Detection of EBV infection at the single-cell level. Precise quantitation of virus-infected cells in vivo. Methods Mol Biol 174: 103-110.
17. Hochberg D, Middeldorp JM, Catalina M, Sullivan JL, Luzuriaga K, et al. (2004) Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A 101: 239-244. (Pubitemid 38084234)
18. Hochberg DR, Thorley-Lawson DA (2005) Quantitative detection of viral gene expression in populations of Epstein-Barr virus-infected cells in vivo. Methods Mol Biol 292: 39-56.
19. Khan G, Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA (1996) Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5: 173-179.
20. Takada K, Ono Y (1989) Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol 63: 445-449. (Pubitemid 19028127)
21. Turk SM, Jiang R, Chesnokova LS, Hutt-Fletcher LM (2006) Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells. J Virol 80: 9628-9633. (Pubitemid 44444661)
22. Chang RS, Lewis JP, Abildgaard CF (1973) Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. N Engl J Med 289: 1325-1329.
23. Golden HD, Chang RS, Prescott W, Simpson E, Cooper TY (1973) Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. J Infect Dis 127: 471-473.
24. Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L (1989) Detection of a second widespread strain of Epstein-Barr virus. Lancet 2: 761-765. (Pubitemid 19234808)
25. Yao QY, Rowe M, Martin B, Young LS, Rickinson AB (1991) The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J Gen Virol 72(Pt 7): 1579-1590.
26. Laichalk LL, Thorley-Lawson DA (2005) Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 79: 1296-1307.
27. Laichalk LL, Hochberg D, Babcock GJ, Freeman RB, Thorley-Lawson DA (2002) The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity 16: 745-754. (Pubitemid 34626694)
28. Pegtel DM, Middeldorp J, Thorley-Lawson DA (2004) Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol 78: 12613-12624. (Pubitemid 39458779)
29. Borza CM, Hutt-Fletcher LM (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8: 594-599. (Pubitemid 34633437)
30. Hutt-Fletcher LM (2007) Epstein-Barr virus entry. J Virol 81: 7825-7832.
31. Andersson-Anvret M, Forsby N, Klein G, Henle W (1977) Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. Int J Cancer 20: 486-494. (Pubitemid 8193335)
32. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, et al. (1985) Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med 313: 1564-1571.
33. Jiang R, Scott RS, Hutt-Fletcher LM (2006) Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42. J Virol 80: 7281-7283. (Pubitemid 44025226)
34. Perry M, Whyte A (1998) Immunology of the tonsils. Immunol Today 19: 414-421.
35. Raab-Traub N (1989) The human DNA tumor viruses: human papilloma virus and Epstein-Barr virus. Cancer Treat Res 47: 285-302.
36. Karimi L, Crawford DH, Speck S, Nicholson LJ (1995) Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus. J Gen Virol 76: 759-765.
37. Tugizov S, Herrera R, Veluppillai P, Greenspan J, Greenspan D, et al. (2007) Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol 81: 5484-5496. (Pubitemid 46846989)
38. Tugizov SM, Berline JW, Palefsky JM (2003) Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med 9: 307-314. (Pubitemid 36362786)
39. Fish KN, Britt W, Nelson JA (1996) A novel mechanism for persistence of human cytomegalovirus in macrophages. J Virol 70: 1855-1862. (Pubitemid 26062949)
40. Luo MH, Fortunato EA (2007) Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells. J Virol 81: 10424-10436.
41. Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, et al. (2008) Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products. Semin Cancer Biol.
42. Miller CL, Lee JH, Kieff E, Longnecker R (1994) An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci U S A 91: 772-776. (Pubitemid 24041484)
43. Chang SS, Lo YC, Chua HH, Chiu HY, Tsai SC, et al. (2008) Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression. J Virol 82: 7745-7751.